Priyanka Reddy Pasnoor
Hyderabad, Telangana, India
1K followers
500+ connections
Hyderabad, Telangana, India
1K followers
500+ connections
About
Five years of experience in Analyzing and reporting of phase I to III clinical data in…
Activity
-
Happy to share that PHUSE #Chapter #meet held at Fortrea #Bengaluru on 27Aug2024 was very #interactive and we had more than 250 #participants. It…
Happy to share that PHUSE #Chapter #meet held at Fortrea #Bengaluru on 27Aug2024 was very #interactive and we had more than 250 #participants. It…
Liked by Priyanka Reddy Pasnoor
-
Condition filtering is a common task in both SAS and R, but the syntax and approaches differ between the two languages. Here’s a comparison of how…
Condition filtering is a common task in both SAS and R, but the syntax and approaches differ between the two languages. Here’s a comparison of how…
Liked by Priyanka Reddy Pasnoor
-
Wat a great privilege to present our Verisian work at PharmaSUG in Beijing. A heartfelt thank you to the organisers and all the inspiring…
Wat a great privilege to present our Verisian work at PharmaSUG in Beijing. A heartfelt thank you to the organisers and all the inspiring…
Liked by Priyanka Reddy Pasnoor
Experience
-
-
-
-
-
-
-
-
-
Education
-
Methodist College of Engineering & Technology
-
-
-
-
-
More activity by Priyanka Reddy
-
Today, I’m excited to share strong Q2 results for Novartis. As the first half of the year comes to a close, I’m incredibly proud of the work our…
Today, I’m excited to share strong Q2 results for Novartis. As the first half of the year comes to a close, I’m incredibly proud of the work our…
Liked by Priyanka Reddy Pasnoor
-
We're proud to announce our first webinar with James 📊 Joseph from EDA CLINICAL who will share his expertise in producing quality clinical trial…
We're proud to announce our first webinar with James 📊 Joseph from EDA CLINICAL who will share his expertise in producing quality clinical trial…
Liked by Priyanka Reddy Pasnoor
-
Thrilled to share that I had the privilege of engaging in an up-close conversation with the esteemed and visionary CEO of Novartis, Dr. Vas…
Thrilled to share that I had the privilege of engaging in an up-close conversation with the esteemed and visionary CEO of Novartis, Dr. Vas…
Liked by Priyanka Reddy Pasnoor
-
Today we announce the FDA approval of a radioligand therapy for pediatric patients living with gastroenteropancreatic neuroendocrine tumors…
Today we announce the FDA approval of a radioligand therapy for pediatric patients living with gastroenteropancreatic neuroendocrine tumors…
Liked by Priyanka Reddy Pasnoor
-
Verisian company summit #2 in Berlin is done! Three days packed with team building, workshopping, sightseeing, escape rooms, good food, drinks, and…
Verisian company summit #2 in Berlin is done! Three days packed with team building, workshopping, sightseeing, escape rooms, good food, drinks, and…
Liked by Priyanka Reddy Pasnoor
-
We are Hiring ! Statistical Programmer-II Great job opportunity for a Statistical Programmer-II. Job Location: Hyderabad /Bangalore. Experience:…
We are Hiring ! Statistical Programmer-II Great job opportunity for a Statistical Programmer-II. Job Location: Hyderabad /Bangalore. Experience:…
Liked by Priyanka Reddy Pasnoor
-
Join over 250 statistical programmers and statisticians at our upcoming Hyderabad event on AI in Statistical Programming. Don't miss this panel…
Join over 250 statistical programmers and statisticians at our upcoming Hyderabad event on AI in Statistical Programming. Don't miss this panel…
Liked by Priyanka Reddy Pasnoor
-
Excited to present our latest Verisian Community Podcast episode. We're welcoming Ritika Aggarwal from Novartis, where she shares her insights on on…
Excited to present our latest Verisian Community Podcast episode. We're welcoming Ritika Aggarwal from Novartis, where she shares her insights on on…
Liked by Priyanka Reddy Pasnoor
Explore collaborative articles
We’re unlocking community knowledge in a new way. Experts add insights directly into each article, started with the help of AI.
Explore More